Access to medicines
Ahead of Gavi Board meeting, MSF calls on Gavi to revise its global mechanism and demand pharma sell all COVID-19 vaccines at cost
Press Release
23 Jun 2020
Too often we cannot treat patients because the medicines are too expensive, or they are no longer produced. Sometimes, the only drugs we have are highly toxic or ineffective and nobody is looking for a better cure.
As a medical humanitarian organisation, it is fundamentally unacceptable that access to essential medicines is increasingly difficult, particularly for the most common global infectious diseases.